TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ADPT

Adaptive Biotechnologies Corp

Healthcare · Diagnostics & Research

29.60$ +6.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADPT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.33 -0.31 1.65 -1.14 -1.37 -1.29 -1.08 -0.65 -0.30
0.05 0.06 0.06 0.06 0.15 0.20 0.15 0.13 0.12
0.07 0.11 0.11 0.19 0.31 0.39 0.44 0.36 0.34
0.07 0.09 0.09 0.19 0.31 0.40 – – –
-0.05 -0.02 2.05 -0.31 -0.40 -0.50 -0.32 -0.12 -0.38
0.02 0.06 0.09 0.14 0.44 0.11 0.07 0.02 0.02
0.35 0.01 -3.87 -0.89 1.29 0.02 0.90 0.53 0.25
0.00 0.00 – – – – – – –
0.47 0.01 2.61 2.24 0.19 0.06 – – –
0.00 0.00 – – 0.00 0.87 – – –
0.47 0.01 2.57 2.24 0.19 0.93 0.02 0.00 0.20
0.49 -0.29 0.35 0.20 0.11 -0.34 -0.17 -0.12 0.15
-0.35 -0.37 1.56 -1.28 -1.81 -1.41 -1.16 -0.67 -0.32

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?